[Rimonabant helps in overweight patients with multiple cardiovascular risk factors such as type 2 diabetes].
Golay
Alain
A
D063387:Cannabinoid Receptor Antagonists; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D050177:Overweight / Q000150:complications*; D010880:Piperidines / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use*; D000077285:Rimonabant
D063387:Cannabinoid Receptor Antagonists; D007004:Hypoglycemic Agents; D010880:Piperidines; D011720:Pyrazoles; D000077285:Rimonabant